Cargando…
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation
BACKGROUND: Barriers to cancer clinical trial participation have been the subject of frequent study, but the rate of trial participation has not changed substantially over time. Studies often emphasize patient-related barriers, but other types of barriers may have greater impact on trial participati...
Autores principales: | Unger, Joseph M, Vaidya, Riha, Hershman, Dawn L, Minasian, Lori M, Fleury, Mark E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410951/ https://www.ncbi.nlm.nih.gov/pubmed/30856272 http://dx.doi.org/10.1093/jnci/djy221 |
Ejemplares similares
-
“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials
por: Unger, Joseph M, et al.
Publicado: (2020) -
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016
por: Vaidya, Riha, et al.
Publicado: (2022) -
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2022) -
Association of National Cancer Institute–Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
por: Unger, Joseph M., et al.
Publicado: (2019) -
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
por: Unger, Joseph M., et al.
Publicado: (2020)